FB2025_01 , released February 20, 2025
Allele: Dmel\GlyRSG240R.UAS.Tag:HA
Open Close
General Information
Symbol
Dmel\GlyRSG240R.UAS.Tag:HA
Species
D. melanogaster
Name
FlyBase ID
FBal0297469
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Key Links
Genomic Maps

Transgenic product class
Nature of the Allele
Transgenic product class
Carried in construct
Cytology
Description

A G240R amino acid replacement has been introduced into GlyRSUAS.Tag:HA.

Allele components
Component
Use(s)
Encoded product / tool
Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Nucleotide change:

G15096237M

Amino acid change:

G240R | GlyRS-PA; G326R | GlyRS-PB; G326R | GlyRS-PC

Reported amino acid change:

G326R

Comment:

Analogous mutation in human GARS implicated in Charcot-Marie-Tooth disease, type 2D; mutation carried on in vitro construct; site of nucleotide substitution in fly gene inferred by FlyBase curator based on reported amino acid change.

Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 1 )
Disease
Evidence
References
Modifiers Based on Experimental Evidence ( 0 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
This allele represents a human variant implicated in disease.
GARS1:p.Gly294Arg
Variants Synonym(s)
GARS1:p.Gly240Arg
Associated human disease model(s)
External database links
Comments concerning this variant
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

Ubiquitous expression of Aats-glyG240R.Scer\UAS.T:Ivir\HA1 under the control of a strong Act5C driver (the P{Act5C-GAL4}25FO1 insertion of Scer\GAL4Act5C.PI) severely impairs fly development at the late pupal stage and yields only 3% escapers. No effect on viability is seen when Aats-glyG240R.Scer\UAS.T:Ivir\HA1 is expressed under the control of another insertion, P{Act5C-GAL4}17bFO1. Expression in the nervous system under the control of Scer\GAL4nSyb.PS has no effect on viability, but progressive climbing impairment is observed at days 20 and 30 compared to wild type.

Flies expressing Aats-glyG240R.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4OK307 exhibit defects in the Giant Fibre-Trochanteral-Motoneuron-Tergotrochanteral Muscle (GF-TTMn-TTM) circuit. Upon GF stimulation, a mild but significant increase in response latencies is seen compared to controls. Following frequencies after a train of stimulations at 100 Hz are reduced compared to wild type.

Expression of Aats-glyG240R.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4GMR.PU has no effect on ommatidial organisation.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Phenotype Manifest In
Additional Comments
Genetic Interactions
Statement
Reference
Xenogenetic Interactions
Statement
Reference
Complementation and Rescue Data
Comments
Images (0)
Mutant
Wild-type
Stocks (0)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (3)
Reported As
Symbol Synonym
Aats-glyG240R.Scer\UAS.T:Ivir\HA1
GlyRSG240R.Scer\UAS.T:Ivir\HA1
GlyRSG240R.UAS.Tag:HA
Name Synonyms
Secondary FlyBase IDs
    References (3)